
At ASCRS, Dr Rom Kandavel discusses iStent outcomes for patients who have undergone laser peripheral iridotomy, trabeculectomy and SLT
At ASCRS, Dr Rom Kandavel discusses iStent outcomes for patients who have undergone laser peripheral iridotomy, trabeculectomy and SLT
At this year's ASCRS meeting, J. Morgan Micheletti, MD, talks about his research and the Young Eye Surgeons (YES) programme
William F. Wiley, MD, shares key takeaways from his presentation on binocularity and stereoacuity
Dr Neda Nikpoor discusses Light Adjustable Lenses and the implications for clinicians at ASCRS 2024
At ASCRS 2024, Aurion Biotech's Global VP Eris Jordan previews upcoming clinical data from North America and Asia
Jascha Wendelstein, MD, discusses the outcomes of a study comparing K and TK measurements
At ASCRS 2024, Oliver Findl, MD, provides an update on the ESCRS IOL calculator and new tools to come this year
Ahead of the ASCRS 2024 meeting, TheiaNova CEO Carissa Fonseca, PhD, pitched a novel keratoconus treatment
At the 2024 ASCRS meeting, Anthony Wallace details the presentations and educational programmes from Bausch + Lomb
At the ASCRS meeting in Boston, Dan Tran, MD, details his presentation on incision quality and clinical outcomes of femtosecond laser
At ASCRS in Boston, Paul Harasymowycz, MD shared a decade's worth of data on MIGS procedures for primary open-angle glaucoma
Adam Muzychuk, MD, BSc, FRCSC, discusses his ASCRS 2024 presentation on toric lens use for patients with low astigmatism
Greg Kunst, CEO of Aurion Biotech, discusses AURN001, a novel cell therapy targeting corneal endothelial disease
At ASCRS2024, George O. Waring IV, MD, FACS, provides an overview of his presentation highlighting outcomes for LASIK performed using an updated laser ablation algorithm
Filomena Ribeiro, MD, PhD, FEBO, discusses her presentation on neuroadaptation following the ASCRS Refractive Day
Sean Hanlon, CEO of CoFi, details the patient and provider benefits of recent CareCredit integration
Rich Small, CEO of Neurotech Pharmaceuticals, provides an update on the months ahead for NT-501 encapsulated cell therapy
The glaucoma specialist talks about navigating the world of research, and the realities of motherhood, as a clinician
Andrew G. Lee, MD, expresses his perspective regarding the necessity of lumbar puncture for all individuals with idiopathic intracranial hypertension, highlighting the importance of clinical judgment and treatment approaches.
Retina specialists Giuseppe Querques, MD, PhD, and Paolo Lanzetta, MD, debate at the Congress on Controversies in Ophthalmology
At this year's Congress on Controversies in Ophthalmology, keynote speaker Ursula Schmidt-Erfurth, MD, addressed the clinical use of artificial intelligence
The retina specialist shares advice for the clinician-scientists of a digital-centric future
Filomena Ribeiro, MD, PhD, FEBO, discusses the crucial role of mentors – and where to find them
Ramin Tadayoni, MD, PhD, highlights data from the BALATON and COMINO Phase 3 studies about faricimab
Dr Jennifer Lim reveals new data on Angiopoietin-2 inhibition and insights on clinical trial design
Anat Loewenstein, MD, illuminates the outcomes of using an AI-based fluid quantification for remote retina monitoring and analysis
Dr Carl Regillo provided an overview of topline results – and a deep dive into subgroup analyses – of DAVIO 2 trial data
Sydney M Crago, editor of Modern Retina, talks with Arshad M Khanani, MD, MA, FASRS, about the expanded efficacy data from the GATHER 2 trial, presented at the 2024 Angiogenesis Symposium
At this year's ESCRS meeting, industry leaders shared advice for young ophthalmologists–and what they wish they'd known earlier in their careers
At AAO 2023, Diana Do, MD, spoke with the Ophthalmology Times team about her presentation of the results for the 96-week PHOTON study of aflibercept for diabetic macular oedema